Effect of Ivermectin on Time to Resolution of Symptoms Among

This randomized trial compares the effects of ivermectin vs placebo on time to symptom resolution within 21 days among patients with mild COVID-19.

Related Keywords

Colombia , Helsinki , Eteläuomen Läi , Finland , Colombian , Nidia Guaza , Elizabeth Toro , Carlos Gonzalez , Camilo Andrade , Mariaf Collazos , Lina Solano , Dianap Mazo , Sanofi Pasteur , Diego Rivera , Carlos Cort , James Riascos , Jenny Yela , Jhonj Calder , Ovidio Maldonado , Mary Luz Hernandez , Hilda Giraldo , Diana Su , Gloria Tamayo , Socorro Mutis , Aracelly Romero , Leidy Gomez , Glaxosmithkline , Group Information , Drug Administration , Colombian National Institute Of Health , Colombian Regulatory Agency , Microsoft , National Early Warning Score , World Health Organization Rd Blueprint , Good Clinical Practice , Centro De Estudios , Colombian National Institute , Microsoft Excel , World Health Organization , National Cancer Institute , Common Terminology Criteria , Adverse Events , Hoc Analysis , Hoc End Points , Interest Disclosures , Merck Sharp , Estudio Para Evaluar , Victoria Aguirre , Eliana Valencia , Laura Victoria , Alexandra Sierra , Carolina Ospina ,